Pacira Pharmaceuticals (PCRX) PT Ratcheted Up to $58 at Jefferies
Tweet Send to a Friend
Jefferies analyst Oren Livnat boosted estimates and the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) from $44 to $58 on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
